Heterologous Antibody Responses Conferred by A(H3N2) Variant and Seasonal Influenza Vaccination Against Newly Emerged 2016-2018 A(H3N2) Variant Viruses in Healthy Persons.

Liu, Feng; Levine, Min Z

Liu, Feng; Levine, Min Z.

Affiliation

Liu F; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Levine MZ; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Clin Infect Dis ; 71(12): 3061-3070, 2020 12 15.

Article in En | MEDLINE | ID: mdl-31858129

Subject(s)

Influenza Vaccines; Influenza, Human; Antibodies, Viral; Antibody Formation; Hemagglutination Inhibition Tests; Humans; Influenza A Virus, H3N2 Subtype/genetics; Influenza, Human/prevention & control; Seasons; Vaccination

Key words

A(H3N2) variant viruses [A(H3N2)v]; HI and MN antibody responses; heterologous antibody responses; influenza vaccine; seasonal influenza A(H3N2) viruses

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human Type of study: Risk_factors_studies Limits: Humans Language: En Year: 2020 Type: Article

Fulltext

XML

PubMed Links

Search on Google